Restoring Biological Harmony for Patients with Debilitating Disease

We are harnessing the power of microRNA science to develop therapies that normalize biological pathways and counterbalance disease.

Learn More

DEVELOPMENT PROGRAMS

Our pipeline is focused on serious diseases of high unmet need where the latest discoveries in microRNA biology are challenging traditional drug development paradigms and creating opportunities for novel therapeutic approaches.

MIRAGEN CEO FEATURED IN BIZWEST

miRagen’s CEO Bill Marshall was interviewed by BizWest about his goal to address three disease categories: blood cancers, which include leukemias and lymphomas; pathologic fibrosis; and cardiovascular disease.

READ ARTICLE >